Optimal Dosing of Oral Anticancer Drugs in Older Adults With Cancer: a Randomized Pilot Study.
Latest Information Update: 01 Dec 2023
At a glance
- Drugs Lenvatinib (Primary) ; Olaparib (Primary) ; Palbociclib (Primary) ; Pazopanib (Primary) ; Sunitinib (Primary)
- Indications Breast cancer; Carcinoma; Endometrial cancer; Ovarian cancer; Renal cancer; Thyroid cancer
- Focus Adverse reactions
- Acronyms OPTI-DOSE
Most Recent Events
- 28 Nov 2023 Planned initiation date changed from 1 Sep 2023 to 1 May 2024.
- 20 Jul 2023 New trial record